CalciMedica, Inc. (CALC) Financial Statements (2026 and earlier)

Company Profile

Business Address 505 COAST BOULEVARD SOUTH
LA JOLLA, CA 92037
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:18,700,00011,200,00039,128,00063,670,00095,033,000
Cash and cash equivalent7,935,0005,530,00017,304,00013,364,00033,418,000
Short-term investments10,734,0005,708,00021,824,00050,306,00061,615,000
Other undisclosed cash, cash equivalents, and short-term investments31,000(38,000)   
Prepaid expense   503,0001,866,000 
Other current assets    1,353,000 
Other undisclosed current assets965,000405,00039,000189,0004,207,000
Total current assets:19,665,00011,605,00039,670,00067,078,00099,240,000
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization119,000167,000 1,981,0001,946,000
Deposits noncurrent assets     608,000
Other undisclosed noncurrent assets10,000413,000 29,000 
Total noncurrent assets:129,000580,000 2,010,0002,554,000
TOTAL ASSETS:19,794,00012,185,00039,670,00069,088,000101,794,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,864,0002,887,0001,916,000831,0003,869,000
Accounts payable1,998,0001,419,0001,716,000527,0002,513,000
Accrued liabilities866,0001,468,000200,000304,0001,356,000
Other liabilities   1,580,0003,226,0003,128,000
Other undisclosed current liabilities820,0001,141,000203,000  
Total current liabilities:3,684,0004,028,0003,699,0004,057,0006,997,000
Noncurrent Liabilities
Liabilities, other than long-term debt    8,00011,000
Deferred rent credit    8,00011,000
Other undisclosed noncurrent liabilities1,700,000    
Total noncurrent liabilities:1,700,000  8,00011,000
Total liabilities:5,384,0004,028,0003,699,0004,065,0007,008,000
Equity
Equity, attributable to parent14,410,0008,157,00035,971,00065,023,00094,786,000
Common stock4,0001,0002,0002,0002,000
Additional paid in capital174,166,000154,218,000240,799,000234,225,000228,155,000
Accumulated other comprehensive income (loss) 4,0002,000(37,000)(16,000)(4,000)
Accumulated deficit(159,764,000)(146,064,000)(204,793,000)(169,188,000)(133,367,000)
Total equity:14,410,0008,157,00035,971,00065,023,00094,786,000
TOTAL LIABILITIES AND EQUITY:19,794,00012,185,00039,670,00069,088,000101,794,000

Income Statement (P&L) (USD)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating expenses(24,204,000)(38,075,000)(36,180,000)(35,947,000)(29,832,000)
Operating loss:(24,204,000)(38,075,000)(36,180,000)(35,947,000)(29,832,000)
Nonoperating income (expense)10,504,0003,718,000575,000126,000143,000
Investment income, nonoperating   575,000126,000143,000
Other nonoperating income1,014,000660,000   
Interest and debt expense     
Loss from continuing operations before equity method investments, income taxes:(13,700,000)(34,357,000)(35,605,000)(35,821,000)(29,689,000)
Other undisclosed income from continuing operations before income taxes     
Loss from continuing operations before income taxes:(13,700,000)(34,357,000)(35,605,000)(35,821,000)(29,689,000)
Income tax expense  (1,000)   
Loss from continuing operations:(13,700,000)(34,358,000)(35,605,000)(35,821,000)(29,689,000)
Loss before gain (loss) on sale of properties:(35,821,000)(29,689,000)
Other undisclosed net income  1,000  2,158,000
Net loss attributable to parent:(13,700,000)(34,357,000)(35,605,000)(35,821,000)(27,531,000)
Preferred stock dividends and other adjustments     (14,378,000)
Other undisclosed net income available to common stockholders, basic     7,189,000
Net loss available to common stockholders, diluted:(13,700,000)(34,357,000)(35,605,000)(35,821,000)(34,720,000)

Comprehensive Income (USD)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(13,700,000)(34,357,000)(35,605,000)(35,821,000)(27,531,000)
Comprehensive loss:(13,700,000)(34,357,000)(35,605,000)(35,821,000)(27,531,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2,0002,000(21,000)(12,000)(7,000)
Comprehensive loss, net of tax, attributable to parent:(13,698,000)(34,355,000)(35,626,000)(35,833,000)(27,538,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: